Roivant Sciences is headquartered in London, United Kingdom.
Roivant Sciences disclosed revenue of 29M USD for 2025 and 33M USD for 2024.
Roivant Sciences has 750 employees.
Roivant Sciences is a life science company.
Roivant Sciences was founded in 2014.
11-12 St. James's Square Suite 1 3rd Floor,
London,
SW1Y 4LB
United Kingdom,
+44 20 7400 3347
www.roivant.com
Roivant Sciences develops transformative medicines faster by building technologies and developing talent in creative ways, leveraging the Roivant platform to launch Vants – nimble and focused biopharmaceutical and health technology companies. Roivant Sciences was founded in 2014 and is based in London, United Kingdom.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.2/yr) | # | - | 1 | - | - | - | - | 1 |
| vol | $450M | $450M | ||||||
| Sell (0.4/yr) | # | - | - | - | 1 | 1 | - | 2 |
| vol | $7.1B | $1.2B | $8.3B | |||||
| 3 | ||||||||
| Financial | Deals |
|---|---|
|
Goldman Sachs |
1 |
| Legal | Deals |
|---|---|
|
Freshfields Bruckhaus Deringer |
2 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
